Powered by bioaccess®
Global Trial Accelerators™
Global Trial Accelerators™
Fast-Tracking First-in-Human Trials, Anywhere Hosted by bioaccess® CEO Julio G. Martínez-Clark and business development director and co-host Jesús E. Moreno, the Global Trial Accelerators™ podcast (formerly LATAM Medtech Leaders) delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia. What You’ll Learn: Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN. Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance. Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites. Why Listen? Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early. Regulatory Intel: Stay ahead of shifting guidelines in LATAM, Eastern Europe, and APAC with on-the-ground experts. Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets. “bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay. This podcast is why we partnered with them.” – Digital Health Startup CEO New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity. Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.
Choose your favorite podcast player
Over 30,000 LinkedIn followers!

Fast-Tracking First-in-Human Trials, Anywhere

The Global Trial Accelerators™ podcast (formerly known as LATAM Medtech Leaders) delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.

Recent

Feb. 1, 2026

Fast-Track Your Breakthrough: First-in-Human Trials 40% Faster | Lati…

🚀 First-in-Human Clinical Trials 40% Faster & 30% Lower Cost | MedTech & Biopharma Startups Struggling with endless delays and skyrocketing costs for your first-in-human studies? Discover the Latin American Advantage — a proven strategy that's transforming how innovative MedTech and biopharma comp…

Watch the Video
Jan. 29, 2026

Alfonso García, CEO & BD Director at Leon Research

In this episode, we’re joined by Alfonso, CEO at Leon Research and Managing Board Member at AICROS, to dive into leadership, growth, and innovation in clinical research. With 14 years of experience in executive and managerial roles—including over a decade in clinical investigation—Alfonso brings a…

Watch the Video
Jan. 29, 2026

Alfonso García, CEO & BD Director at Leon Research

In this episode, we welcome Alfonso , CEO at Leon Research and Managing Board Member and Marketing Director at AICROS , for an in-depth conversation on leadership, clinical research, and business development in the pharmaceut...

Listen to the Episode
Jan. 29, 2026

Justin Chickles, CEO & Co-Founder of Glycyx Therapeutics

In this episode of Global Trial Accelerators, we sit down with Justin Chickles, CEO and co-founder of Glycyx Therapeutics, a clinical-stage biotech company taking on a hidden threat to cancer immunotherapy success: opioids. With over two decades of leadership across therapeutics, diagnostics, and …

Watch the Video
Jan. 15, 2026

Steven Collens, CEO at MATTER

In this episode, we welcome Steven Collens, CEO of MATTER, one of the world’s leading healthcare incubators and innovation hubs. Under Steven’s leadership, MATTER has supported more than 1,000 healthcare startups, helping innovators move faster, collaborate more effectively, and significantly impro…

Watch the Video
Jan. 15, 2026

Steven Collens, CEO at MATTER

This episode features Steven Collens, CEO of MATTER, a premier healthcare incubator and innovation hub that has supported over 1,000 healthcare startups. MATTER helps entrepreneurs and organizations innovate faster and more efficiently while increasing the likelihood of long-term success. Founde…

Listen to the Episode

Recent Blog Posts

Jan. 22, 2026

Demystifying Clinical Solutions: An Interview with Matteo Talotta

Welcome back to the blog, fellow explorers of innovation! In our latest podcast episode, we had the incredible opportunity to sit down with Matteo Talotta, a true visionary in the field of clinical solutions. Our conversation was so rich with insigh…

Read the Blog Post
Jan. 22, 2026

Building a Culture of Innovation: Lessons from Uvisa Health

Welcome back to the podcast blog! In our latest episode, we had the immense pleasure of speaking with Sonal Pendharkar Kulkarni, the brilliant Co-founder and Chief Scientific Officer at Uvisa Health. Her insights were truly illuminating, and today, …

Read the Blog Post
Nov. 12, 2025

Building a Winning Team: David Kraemer's Perspective on Talent Acquis…

In today's fast-paced business environment, building a high-performing team is paramount to achieving sustainable success. Nowhere is this truer than in the demanding world of private equity, where the stakes are high and the pressure to deliver exc…

Read the Blog Post

About the Hosts

Julio G Martinez-Clark Profile Photo
Julio G Martinez-Clark

CEO, bioaccess®

Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech, Biopharma, and Radiopharma innovation by positioning Latin America, Eastern Europe (the Balkans), and Australia as global leaders in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.

Jesus E. Moreno Profile Photo
Jesus E. Moreno

Business Development Director, bioaccess®

Jesus E. Moreno is a business development director who provides efficient and reliable clinical research services in Latin America. With a passion for driving innovation in the healthcare sector, Jesus leverages his bilingual biomedical engineering background and his understanding of the unique challenges that Medtech startups face to provide valuable support and deliver accelerated clinical study results. Jesus profoundly understands the critical role that reliable and streamlined clinical research plays in the success of Medtech startups. He firmly believes that by offering cost-effective solutions without compromising quality, Medtech startups can achieve their clinical goals faster and make a meaningful impact in the healthcare industry. Jesus is passionate about supporting Medtech startups in their journey towards bringing innovative medical technologies to market. Jesus possesses the technical expertise to understand the complexities of medical devices and technologies. This knowledge enables him to identify tailored solutions that meet the specific needs of Medtech startups. Jesus has a bachelor's degree in biomedical engineering and a master's degree in electronics engineering.